港股异动 | 德适-B(02526.HK)涨超9% 纳入恒生综合指数9月7日生效

智通财经

Sep 02

智通财经APP获悉，德适-B(02526.HK)涨超9%，截至发稿，涨9.42%，报569港元，成交额1737.74万港元，最高涨幅逾11%。该股年内累涨474.75%。今日所属医疗设备及用品板块大涨4.51%，板块β与个股α共振，助推德适走高。

8月21日恒生指数公司公布季检结果，相关调整将于9月7日生效。德适已符合纳入港股通交易的标准，且是本次指数调整中唯一获纳入恒生生物科技指数的公司。浦银国际研报指出，追踪恒指、恒科、国企指数三大指数的被动基金规模合计约7963亿港元，预计带来约386亿港元双向资金流动，入通临近资金抢筹情绪升温。

德适自研 iMedImage® 医疗影像基座大模型，并以此为基础搭建 iMedLoop™ 医疗影像AI研究与生产加速平台，构筑"底座—平台—产品"三位一体，实现AI医疗商业化全链路闭环，是全球医疗影像AI工业化平台公司。

围绕基座模型，德适已形成三层能力体系：底层 iMedImage® 提供可跨影像模态、器官与疾病复用的影像理解与推理能力；中层 iMedStudio™、iMedMaaS®、DoctorBench® 构成覆盖数据处理与标注质控、模型训练评测及部署的标准化工具链；7月上线的iMedLoop™再将数据接入、模型训练、统一评测、发布部署与应用反馈连为一体。公司将持续推进基座模型迭代、专科模型开发及医院场景部署，推动医疗影像AI向平台化、规模化应用延展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2664911198"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664911198\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664911198?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-09-02 14:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664911198","market":"hk","top_or_hot":-1,"title":"港股异动 | 德适-B(02526.HK)涨超9% 纳入恒生综合指数9月7日生效","media":"智通财经","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/02526\">德适-B</a>(02526.HK)涨超9%，截至发稿，涨9.42%，报569港元，成交额1737.74万港元，最高涨幅逾11%。该股年内累涨474.75%。今日所属医疗设备及用品板块大涨4.51%，板块β与个股α共振，助推德适走高。</p><p>8月21日恒生指数公司公布季检结果，相关调整将于9月7日生效。德适已符合纳入港股通交易的标准，且是本次指数调整中唯一获纳入恒生生物科技指数的公司。浦银国际研报指出，追踪恒指、恒科、国企指数三大指数的被动基金规模合计约7963亿港元，预计带来约386亿港元双向资金流动，入通临近资金抢筹情绪升温。</p><p>德适自研 iMedImage® 医疗影像基座大模型，并以此为基础搭建 iMedLoop™ 医疗影像AI研究与生产加速平台，构筑\"底座—平台—产品\"三位一体，实现AI医疗商业化全链路闭环，是全球医疗影像AI工业化平台公司。</p><p>围绕基座模型，德适已形成三层能力体系：底层 iMedImage® 提供可跨影像模态、器官与疾病复用的影像理解与推理能力；中层 iMedStudio™、iMedMaaS®、DoctorBench® 构成覆盖数据处理与标注质控、模型训练评测及部署的标准化工具链；7月上线的iMedLoop™再将数据接入、模型训练、统一评测、发布部署与应用反馈连为一体。公司将持续推进基座模型迭代、专科模型开发及医院场景部署，推动医疗影像AI向平台化、规模化应用延展。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 德适-B(02526.HK)涨超9% 纳入恒生综合指数9月7日生效</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 德适-B(02526.HK)涨超9% 纳入恒生综合指数9月7日生效\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-02 14:58 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1490860.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，德适-B(02526.HK)涨超9%，截至发稿，涨9.42%，报569港元，成交额1737.74万港元，最高涨幅逾11%。该股年内累涨474.75%。今日所属医疗设备及用品板块大涨4.51%，板块β与个股α共振，助推德适走高。8月21日恒生指数公司公布季检结果，相关调整将于9月7日生效。德适已符合纳入港股通交易的标准，且是本次指数调整中唯一获纳入恒生生物科技指数的公司。浦银国际...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1490860.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSCI","symbol_name":"恒生综合指数","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1490860.html","article_id":"2664911198","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664911198","pubTimestamp":1788332310,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，德适-B涨超9%，截至发稿，涨9.42%，报569港元，成交额1737.74万港元，最高涨幅逾11%。该股年内累涨474.75%。今日所属医疗设备及用品板块大涨4.51%，板块β与个股α共振，助推德适走高。8月21日恒生指数公司公布季检结果，相关调整将于9月7日生效。德适已符合纳入港股通交易的标准，且是本次指数调整中唯一获纳入恒生生物科技指数的公司。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HSCI":"恒生综合指数","BK4585":"ETF&股票定投概念","02526":"德适-B","VXUS":"国际股票ETF-Vanguard","KCAI":"KraneShares China Alpha Index ETF","BK4588":"碎股","BK1100":"医疗保健设备"},"translate_title":"Hong Kong Stocks in Focus | Deshi-B (02526.HK) Rises Over 9% Inclusion in Hang Seng Composite Index Effective September 7","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1.5,"02526":1.5,"KCAI":1.5,"HSCI":1.5},"content_text":"智通财经APP获悉，德适-B(02526.HK)涨超9%，截至发稿，涨9.42%，报569港元，成交额1737.74万港元，最高涨幅逾11%。该股年内累涨474.75%。今日所属医疗设备及用品板块大涨4.51%，板块β与个股α共振，助推德适走高。8月21日恒生指数公司公布季检结果，相关调整将于9月7日生效。德适已符合纳入港股通交易的标准，且是本次指数调整中唯一获纳入恒生生物科技指数的公司。浦银国际研报指出，追踪恒指、恒科、国企指数三大指数的被动基金规模合计约7963亿港元，预计带来约386亿港元双向资金流动，入通临近资金抢筹情绪升温。德适自研 iMedImage® 医疗影像基座大模型，并以此为基础搭建 iMedLoop™ 医疗影像AI研究与生产加速平台，构筑\"底座—平台—产品\"三位一体，实现AI医疗商业化全链路闭环，是全球医疗影像AI工业化平台公司。围绕基座模型，德适已形成三层能力体系：底层 iMedImage® 提供可跨影像模态、器官与疾病复用的影像理解与推理能力；中层 iMedStudio™、iMedMaaS®、DoctorBench® 构成覆盖数据处理与标注质控、模型训练评测及部署的标准化工具链；7月上线的iMedLoop™再将数据接入、模型训练、统一评测、发布部署与应用反馈连为一体。公司将持续推进基座模型迭代、专科模型开发及医院场景部署，推动医疗影像AI向平台化、规模化应用延展。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}